psychedelics investing Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology
psychedelics investing Emyria Selected by Reach Wellness to Lead MDMA -Assisted Therapy Research for First Responders
life science investing Emyria’s Specialist Psychiatrist Granted Authorised Prescriber Status in MDMA-Assisted Therapy for PTSD
cannabis investing Eminent Healthcare Leader Appointed as Independent Non-Executive Chairman for Emyria Ltd
Torchlight Innovations (Doing Business as RZOLV Technologies) Announces Preliminary Positive Results on Rare Earth and Critical Mineral Recoveries
